Yeast Beta-glucan Market Size & Growth Forecast 2026–2035, By Segments (Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Yeast Beta-glucan Market size was valued at USD 229.48 Million in 2025 and is anticipated to grow at a 8.2% CAGR from 2026 to 2035, attaining USD 504.68 Million by 2035. The industry revenue for 2026 is assessed at USD 246.01 million.

• Base Year Value (2025): USD 229.48 Million
• CAGR (2026-2035): 8.2%
• Forecast Year Value (2035): USD 504.68 Million
• Historical Data Period: 2022-2025
• Largest Region: Asia Pacific
• Forecast Period: 2026-2035

Yeast Beta-glucan Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Asia Pacific held a 32.40% share in 2025 due to its large functional ingredient manufacturing base and strong demand across food, beverage, nutraceutical, and feed applications.
  • Europe is projected to grow at a 9.27% CAGR, driven by stronger adoption of functional ingredients for immune support, gut health, and clean-label nutrition products.

• Segment Momentum:

  • Food & Beverages accounted for 32.4% of the market in 2025 because yeast beta-glucan is widely incorporated into functional foods and nutrition-focused products, supporting stable commercial demand.
  • Animal Feed is the fastest-growing application as producers increasingly adopt yeast beta-glucan in feed formulations that support livestock health and production efficiency.

• Market Expansion Drivers:

  • Growing functional food and animal feed applications increasing yeast beta-glucan demand.
  • Rising chronic diseases and aging population driving immune-boosting ingredient consumption.
  • Expansion of nutraceutical formulations integrating beta-glucan into mainstream dietary supplements.

• Leading Market Participants:

  Major players in the yeast beta-glucan market include Cargill, Incorporated (USA), Lesaffre Group (France), Kerry Group plc (Ireland), Lallemand Inc. (Canada), Angel Yeast Co., Ltd. (China), Leiber GmbH (Germany), Biorigin (Brazil), DSM-Firmenich AG (Netherlands), Archer Daniels Midland Company (USA), Tate & Lyle PLC (United Kingdom).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 229.48 Million
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 504.68 Million by 2035
  • Growth Forecasts: 8.2% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: Asia Pacific
  • High-Growth Regional Hub: Europe
  • Core Revenue Segment: Food & Beverages (Application)
  • Emerging Opportunity Segment: Animal Feed (Application)

Market Growth Drivers and Industry Trends

Growing functional food and animal feed applications increasing yeast beta-glucan demand

As product developers look for ingredients that can deliver both formulation value and a credible health position, yeast beta-glucan is gaining wider use in functional foods and feed premixes. In the yeast beta-glucan market, this is driving demand from food manufacturers seeking immune-support and wellness positioning in beverages, bakery, dairy alternatives, and fortified products, while feed producers are using the ingredient to support animal resilience, gut health, and performance under tighter antibiotic-use standards. The result is a broader customer base for suppliers, with purchasing decisions increasingly tied to ingredient traceability, efficacy consistency, and compatibility with large-scale food and feed processing.

Rising chronic diseases and aging population driving immune-boosting ingredient consumption

Shifts in consumer health priorities are changing supplement and wellness purchasing behavior, especially as older populations and people managing long-term conditions place greater emphasis on preventive nutrition. That dynamic is reinforcing market demand in the yeast beta-glucan market because immune-support ingredients are being selected not only for short-term wellness trends but also for regular, sustained use in daily health routines. Brands respond by expanding condition-adjacent product lines focused on healthy aging, immune maintenance, and recovery support, which increases repeat inclusion of yeast beta-glucan in capsule, powder, and functional nutrition formats.

Expansion of nutraceutical formulations integrating beta-glucan into mainstream dietary supplements

The shift of beta-glucan from a specialty ingredient into standard supplement architecture is strengthening market development by making it easier for nutraceutical brands to incorporate it into established product categories. In the yeast beta-glucan market, formulators are integrating the ingredient into immunity, digestive health, and healthy aging blends, where it can be combined with vitamins, minerals, probiotics, or botanicals without requiring an entirely new product proposition. This practical fit with mainstream supplement development shortens commercialization cycles, expands shelf presence in retail and online channels, and supports market expansion through more frequent product launches and wider consumer exposure.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing functional food and animal feed applications increasing yeast beta-glucan demand	1.70%	Moderate	Asia Pacific, North America	High	Near Term
Rising chronic diseases and aging population driving immune-boosting ingredient consumption	1.90%	Moderate	North America, Europe	High	Near Term
Expansion of nutraceutical formulations integrating beta-glucan into mainstream dietary supplements	1.40%	Moderate	Asia Pacific, North America	Medium	Mid Term

Regional Demand Dynamics

Asia Pacific (Largest Region) vs Europe (Fastest-Growing Region)

Asia Pacific held a 32.40% share of the yeast beta-glucan market in 2025, bolstered by the region’s broad manufacturing base for functional ingredients and its strong downstream demand from food, beverage, nutraceutical, and feed applications. Its leadership is reinforced by the scale at which processors and formulators operate across major economies, where ingredient sourcing, production, and incorporation into health-focused products are already embedded in established supply chains. This practical integration allows suppliers to serve high-volume requirements efficiently while meeting diverse application needs, which helps sustain the region’s leading position.

Europe is projected to expand at a 9.27% CAGR over the forecast period in the yeast beta-glucan market, driven by accelerating use of scientifically positioned functional ingredients in nutrition and wellness products. Growth in the region is being impelled by stronger adoption in formulations where immune support, gut health, and clean-label positioning directly influence purchasing and product development decisions. As manufacturers refine product claims, ingredient quality standards, and application formats, demand is rising in ways that translate into more frequent incorporation of yeast beta-glucan across commercially active end-use categories.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Nascent	Nascent
Cost-Sensitive Region	Medium	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Moderate	Strong	Weak	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	Medium	High	Low	Low
New Entrants / Startups	Dense	Moderate	Dense	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Key Country Insights

United States

Functional Ingredient Innovation

The U.S. yeast beta-glucan market benefits from growing demand for immune-support and functional nutrition ingredients. Manufacturers in the U.S. expand research, product development, and application across dietary supplements, food, and beverage formulations.

Japan

Preventive Health Applications

Japan incorporates yeast beta-glucan into functional foods and nutritional products aligned with preventive health trends. Ingredient suppliers in Japan emphasize product purity, formulation compatibility, and consumer confidence in scientifically supported wellness solutions.

South Korea

Nutraceutical Product Development

South Korea expands yeast beta-glucan applications across dietary supplements and functional food innovations. Manufacturers in South Korea invest in ingredient refinement and value-added formulations that respond to growing consumer interest in daily wellness products.

Germany

Science-Based Formulations

Germany prioritizes clinically supported ingredient development and quality assurance for yeast beta-glucan products. Companies in Germany focus on standardized production processes and evidence-based formulations to serve nutrition and health product manufacturers.

France

Clean Label Nutrition

France supports yeast beta-glucan adoption through demand for natural and clean-label functional ingredients. Companies in France integrate yeast-derived ingredients into health-oriented food and supplement products while maintaining high quality and traceability standards.

Italy

Functional Food Integration

Italy increasingly incorporates yeast beta-glucan into nutritional foods and wellness-focused consumer products. Ingredient suppliers in Italy collaborate with food manufacturers to develop formulations that balance health benefits, taste, and product stability.

Segment Leadership and Growth Trends

  Application Segment Analysis: Food & Beverages (Largest Segment) vs Animal Feed (Fastest-Growing Segment)

Food & Beverages held the dominant position in the yeast beta-glucan market in 2025, accounting for a 32.4% share. This leadership is underpinned by the segment’s broad commercial use in functional foods, beverages, and nutrition-focused formulations where yeast beta-glucan is incorporated to align with demand for health-oriented ingredients. Its established integration into mainstream food and beverage product development helps sustain volume demand, giving Food & Beverages a stable base of consumption and reinforcing its share within the yeast beta-glucan market.

Animal Feed is emerging as the fastest-growing application in the yeast beta-glucan market as feed producers increasingly focus on ingredient solutions that support livestock health and performance under more efficiency-driven production conditions. The segment is gaining momentum because yeast beta-glucan fits practical feed formulation needs in a way that is directly tied to animal management outcomes, making adoption more compelling relative to more established application areas. As feed manufacturers and producers look for functional inputs with clear use-case value, Animal Feed is seeing stronger growth traction within the yeast beta-glucan market.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Application	Food & Beverages, Personal Care & Cosmetics, Pharmaceuticals, Animal Feed, Others	Food & Beverages	Animal Feed

Competitive Landscape and Market Positioning

Prominent players in the yeast beta-glucan market:

1. Cargill Incorporated (USA)

2. Lesaffre Group (France)

3. Kerry Group plc (Ireland)

4. Lallemand Inc. (Canada)

5. Angel Yeast Co. Ltd. (China)

6. Leiber GmbH (Germany)

7. Biorigin (Brazil)

8. DSM-Firmenich AG (Netherlands)

9. Archer Daniels Midland Company (USA)

10. Tate & Lyle PLC (United Kingdom)

The yeast beta-glucan market is gaining momentum due to increasing awareness of functional health ingredients. In the yeast beta-glucan market, scientific research is expanding application possibilities across nutrition and wellness sectors. Collaborative development efforts are improving ingredient functionality and formulation stability. Rising demand for immune-supporting ingredients is driving broader adoption in food and supplement applications.

Industry Development/News

Company Name	Date	Key Development
Angel Yeast	Apr-25	Angel Yeast reported clinical trial findings showing that daily intake of yeast beta-glucan may support symptom improvement in mild cognitive impairment. The study expands potential applications of yeast beta-glucan beyond immune health into cognitive wellness nutraceutical formulations, strengthening its positioning in functional ingredient development.
Kemin Industries	Jun-23	Kemin Industries received Thai FDA approval for BetaVia Complete as a novel food ingredient, supporting its use in dietary supplements for immune health. The approval validates regulatory acceptance of its bioactive beta-glucan formulation and expands commercialization potential in functional nutrition markets.
Kemin Industries	Dec-22	Kemin Industries expanded its Cavriago production facility to increase manufacturing capacity for beta-glucan products used in animal nutrition and health applications. The expansion strengthens supply capabilities and supports growing demand for functional bioactive ingredients in the global nutrition market.
Angel Yeast	Dec-21	Angel Yeast initiated a large-scale yeast production expansion project targeting an annual capacity increase of 20,000 tons, scheduled for completion in May 2024. The investment strengthens its manufacturing footprint and enhances its ability to meet rising global demand for yeast-derived bioactive ingredients including beta-glucans.
Lesaffre Human Care	Jun-20	Lesaffre Human Care acquired a majority stake in Biohymn Biotechnology, a Chinese yeast and yeast extract producer, to strengthen its presence in the Chinese market. The acquisition enhances regional production capabilities and supports strategic expansion of yeast-derived ingredient offerings across Asia.